Docs don't heed safety warning on BMS steroid

Despite a new label warning against epidural injections of Bristol-Myers Squibb's ($BMY) steroid Kenalog, doctors are still using the drug in that manner. "It is still being given in abundance," one pain-management doctor told Bloomberg, while safety experts say the FDA didn't do enough to highlight the label change. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

The agency has granted Tecentriq a priority review in previously untreated NSCLC, setting up the Roche drug for an approval decision by June 19.

Warren Buffett's Berkshire Hathaway has built a $192 million stake in Biogen, a risky investment considering aducanumab's uncertain future.